Attached files
file | filename |
---|---|
8-K - FORM 8-K - Actua Corp | d638939d8k.htm |
EX-99.1 - EX-99.1 - Actua Corp | d638939dex991.htm |
Exhibit 99.2
On December 4, 2013, the acquisition of ICG Group, Inc.s (ICGs) consolidated subsidiary, Procurian Inc. (Procurian), by an affiliate of Accenture plc (Accenture) (such transaction, the Transaction) was consummated. As a result of the Transaction, ICG is providing pro forma financial information with respect to (a) ICGs consolidated balance sheet as of September 30, 2013, (b) ICGs consolidated statements of operations for the nine months ended September 30, 2013 and September 30, 2012, and (c) ICGs consolidated statements of operations for the years ended December 31, 2012, 2011 and 2010. The pro forma financial information reflects, among other things, (i) the removal of Procurians results, as well as the consolidated tax impact related to Procurians removal, from ICGs consolidated results, (ii) ICGs receipt of the estimated cash proceeds in the Transaction and an estimated resultant gain and (iii) ICGs payment of the estimated costs associated with the Transaction.
ICG GROUP, INC.
PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEETS
As of September 30, 2013
(Unaudited)
Historical ICG Group, Inc. (4) |
Sale of Procurian |
Pro Forma ICG Group, Inc. |
||||||||||
Assets |
||||||||||||
Current Assets |
||||||||||||
Cash and cash equivalents |
$ | 58,621 | $ | 308,711 | (1) | $ | 367,332 | |||||
Restricted cash |
557 | | 557 | |||||||||
Accounts receivable, net of allowance |
13,261 | | 13,261 | |||||||||
Prepaid expenses and other current assets |
3,921 | | 3,921 | |||||||||
Assets held for sale |
143,101 | (143,101 | )(2) | | ||||||||
|
|
|
|
|
|
|||||||
Total current assets |
219,461 | 165,610 | 385,071 | |||||||||
Fixed assets, net |
6,297 | | 6,297 | |||||||||
Goodwill |
88,989 | | 88,989 | |||||||||
Intangibles, net |
61,871 | | 61,871 | |||||||||
Cost and equity method investments |
30,048 | | 30,048 | |||||||||
Other assets, net |
1,189 | | 1,189 | |||||||||
|
|
|
|
|
|
|||||||
Total Assets |
$ | 407,855 | $ | 165,610 | $ | 573,465 | ||||||
|
|
|
|
|
|
|||||||
Liabilities |
||||||||||||
Current Liabilities |
||||||||||||
Current maturities of long-term debt |
$ | 5,081 | $ | | $ | 5,081 | ||||||
Accounts payable |
2,146 | | 2,146 | |||||||||
Accrued expenses |
4,117 | | 4,117 | |||||||||
Accrued compensation and benefits |
6,214 | | 6,214 | |||||||||
Deferred revenue |
23,620 | | 23,620 | |||||||||
Liabilities held for sale |
38,814 | (45,158 | )(2) | (6,344 | ) | |||||||
|
|
|
|
|
|
|||||||
Total current liabilities |
79,992 | (45,158 | ) | 34,834 | ||||||||
Long-term debt |
7,922 | | 7,922 | |||||||||
Deferred revenue |
213 | | 213 | |||||||||
Other liabilities |
1,422 | | 1,422 | |||||||||
|
|
|
|
|
|
|||||||
Total Liabilities |
89,549 | (45,158 | ) | 44,391 | ||||||||
|
|
|
|
|
|
|||||||
Redeemable noncontrolling interest |
3,963 | | 3,963 | |||||||||
|
|
|
|
|
|
|||||||
Equity |
||||||||||||
ICG Group, Inc.s Stockholders Equity |
||||||||||||
Preferred stock, $0.01 par value; 10,000 shares authorized, none issued or outstanding |
| | | |||||||||
Common stock, $0.001 par value; 2,000,000 shares authorized, 42,437 shares (2013) issued |
42 | | 42 | |||||||||
Treasury stock, at cost, 4,853 shares (2013) |
(36,409 | ) | | (36,409 | ) | |||||||
Additional paid-in capital |
3,555,908 | | 3,555,908 | |||||||||
Accumulated deficit |
(3,245,866 | ) | 221,869 | (3) | (3,023,997 | ) | ||||||
Accumulated other comprehensive income |
128 | (89 | )(2) | 39 | ||||||||
|
|
|
|
|
|
|||||||
Total ICG Group, Inc.s Stockholders Equity |
273,803 | 221,780 | 495,583 | |||||||||
Noncontrolling Interest |
40,540 | (11,012 | )(2) | 29,528 | ||||||||
|
|
|
|
|
|
|||||||
Total Equity |
314,343 | 210,768 | 525,111 | |||||||||
|
|
|
|
|
|
|||||||
Total Liabilities, Redeemable noncontrolling interest and Equity |
$ | 407,855 | $ | 165,610 | $ | 573,465 | ||||||
|
|
|
|
|
|
See accompanying notes to unaudited pro forma condensed consolidated financial statements.
ICG GROUP, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
For nine months ended September 30, 2013
(In Thousands, Except Per Share Data)
(Unaudited)
Historical ICG Group, Inc. (6) |
Sale of Procurian (8) |
Pro Forma ICG Group, Inc. |
||||||||||
Revenue |
$ | 41,521 | $ | | $ | 41,521 | ||||||
Operating expenses |
||||||||||||
Cost of revenue |
14,061 | | 14,061 | |||||||||
Sales and marketing |
19,634 | | 19,634 | |||||||||
General and administrative |
24,447 | | 24,447 | |||||||||
Research and development |
5,075 | | 5,075 | |||||||||
Amortization of intangible assets |
6,211 | | 6,211 | |||||||||
Impairment related and other |
767 | | 767 | |||||||||
|
|
|
|
|
|
|||||||
Total operating expenses |
70,195 | | 70,195 | |||||||||
|
|
|
|
|
|
|||||||
Operating income (loss) |
(28,674 | ) | | (28,674 | ) | |||||||
Other income (loss), net |
(178 | ) | | (178 | ) | |||||||
Interest income |
150 | | 150 | |||||||||
Interest expense |
(1,076 | ) | | (1,076 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) before income taxes, equity loss and noncontrolling interest |
(29,778 | ) | | (29,778 | ) | |||||||
Income tax (expense) benefit |
1,633 | (1,794 | ) | (161 | ) | |||||||
Equity loss |
(1,919 | ) | | (1,919 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations |
(30,064 | ) | (1,794 | ) | (31,858 | ) | ||||||
Less: Income (loss) from continuing operations attributable to the noncontrolling interest |
(3,255 | ) | | (3,255 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations attributable to ICG Group, Inc. |
$ | (26,809 | ) | $ | (1,794 | ) | $ | (28,603 | ) | |||
|
|
|
|
|
|
|||||||
Basic income (loss) from continuing operations per share attributable to ICG Group, Inc.: |
$ | (0.74 | ) | $ | (0.04 | ) | $ | (0.78 | ) | |||
|
|
|
|
|
|
|||||||
Shares used in computation of basic income (loss) per share |
36,494 | 36,494 | 36,494 | |||||||||
|
|
|
|
|
|
|||||||
Diluted income (loss) from continuing operations per share attributable to ICG Group, Inc.: |
$ | (0.74 | ) | $ | (0.04 | ) | $ | (0.78 | ) | |||
|
|
|
|
|
|
|||||||
Shares used in computation of diluted income (loss) per share |
36,494 | 36,494 | 36,494 | |||||||||
|
|
|
|
|
|
See accompanying notes to unaudited pro forma condensed consolidated financial statements.
ICG GROUP, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
For nine months ended September 30, 2012
(In Thousands, Except Per Share Data)
(Unaudited)
Historical ICG Group, Inc. (6) |
Sale of Procurian (8) |
Pro Forma ICG Group, Inc. |
||||||||||
Revenue |
$ | 17,609 | $ | | $ | 17,609 | ||||||
Operating expenses |
||||||||||||
Cost of revenue |
7,165 | | 7,165 | |||||||||
Sales and marketing |
8,377 | | 8,377 | |||||||||
General and administrative |
20,631 | | 20,631 | |||||||||
Research and development |
4,901 | | 4,901 | |||||||||
Amortization of intangible assets |
3,318 | | 3,318 | |||||||||
Impairment related and other |
795 | | 795 | |||||||||
|
|
|
|
|
|
|||||||
Total operating expenses |
45,187 | | 45,187 | |||||||||
|
|
|
|
|
|
|||||||
Operating income (loss) |
(27,578 | ) | | (27,578 | ) | |||||||
Other income (loss), net |
32,849 | | 32,849 | |||||||||
Interest income |
325 | | 325 | |||||||||
Interest expense |
| | | |||||||||
|
|
|
|
|
|
|||||||
Income (loss) before income taxes, equity loss and noncontrolling interest |
5,596 | | 5,596 | |||||||||
Income tax (expense) benefit |
2,884 | (2,952 | ) | (68 | ) | |||||||
Equity loss |
(7,147 | ) | | (7,147 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations |
1,333 | (2,952 | ) | (1,619 | ) | |||||||
Less: Income (loss) from continuing operations attributable to the noncontrolling interest |
(872 | ) | | (872 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations attributable to ICG Group, Inc. |
$ | 2,205 | $ | (2,952 | ) | $ | (747 | ) | ||||
|
|
|
|
|
|
|||||||
Basic income (loss) from continuing operations per share attributable to ICG Group, Inc.: |
$ | 0.06 | $ | (0.08 | ) | $ | (0.02 | ) | ||||
|
|
|
|
|
|
|||||||
Shares used in computation of basic income (loss) per share |
35,907 | 35,907 | 35,907 | |||||||||
|
|
|
|
|
|
|||||||
Diluted income (loss) from continuing operations per share attributable to ICG Group, Inc.: |
$ | 0.06 | $ | (0.08 | ) | $ | (0.02 | ) | ||||
|
|
|
|
|
|
|||||||
Shares used in computation of diluted income (loss) per share |
36,435 | 36,435 | 35,907 | |||||||||
|
|
|
|
|
|
See accompanying notes to unaudited pro forma condensed consolidated financial statements.
ICG GROUP, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
For twelve months ended December 31, 2012
(In Thousands, Except Per Share Data)
(Unaudited)
Historical ICG Group, Inc.(5) |
Sale of Procurian (7) |
Pro Forma ICG Group, Inc. |
||||||||||
Revenue |
$ | 166,593 | $ | (139,953 | ) | $ | 26,640 | |||||
Operating expenses |
||||||||||||
Cost of revenue |
105,762 | (95,404 | ) | 10,358 | ||||||||
Sales and marketing |
21,920 | (9,770 | ) | 12,150 | ||||||||
General and administrative |
38,805 | (9,682 | ) | 29,123 | ||||||||
Research and development |
14,175 | (6,777 | ) | 7,398 | ||||||||
Amortization of intangible assets |
5,590 | (753 | ) | 4,837 | ||||||||
Impairment related and other |
1,548 | (418 | ) | 1,130 | ||||||||
|
|
|
|
|
|
|||||||
Total operating expenses |
187,800 | (122,804 | ) | 64,996 | ||||||||
|
|
|
|
|
|
|||||||
Operating income (loss) |
(21,207 | ) | (17,149 | ) | (38,356 | ) | ||||||
Other income (loss), net |
57,879 | (59 | ) | 57,820 | ||||||||
Interest income |
442 | (45 | ) | 397 | ||||||||
Interest expense |
(526 | ) | 542 | 16 | ||||||||
|
|
|
|
|
|
|||||||
Income (loss) before income taxes, equity loss and noncontrolling interest |
36,588 | (16,711 | ) | 19,877 | ||||||||
Income tax (expense) benefit |
(1,336 | ) | 1,228 | (108 | ) | |||||||
Equity loss |
(8,672 | ) | | (8,672 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations |
26,580 | (15,483 | ) | 11,097 | ||||||||
Less: Income (loss) from continuing operations attributable to the noncontrolling interest |
368 | (1,961 | ) | (1,593 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations attributable to ICG Group, Inc. |
$ | 26,212 | $ | (13,522 | ) | $ | 12,690 | |||||
|
|
|
|
|
|
|||||||
Basic income (loss) from continuing operations per share attributable to ICG Group, Inc.: |
$ | 0.73 | $ | (0.38 | ) | $ | 0.35 | |||||
|
|
|
|
|
|
|||||||
Shares used in computation of basic income (loss) per share |
35,890 | 35,890 | 35,890 | |||||||||
|
|
|
|
|
|
|||||||
Diluted income (loss) from continuing operations per share attributable to ICG Group, Inc.: |
$ | 0.72 | $ | (0.37 | ) | $ | 0.35 | |||||
|
|
|
|
|
|
|||||||
Shares used in computation of diluted income (loss) per share |
36,543 | 36,543 | 36,543 | |||||||||
|
|
|
|
|
|
See accompanying notes to unaudited pro forma condensed consolidated financial statements.
ICG GROUP, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
For twelve months ended December 31, 2011
(In Thousands, Except Per Share Data)
(Unaudited)
Historical ICG Group, Inc.(5) |
Sale of Procurian (7) |
Pro Forma ICG Group, Inc. |
||||||||||
Revenue |
$ | 133,437 | $ | (120,552 | ) | $ | 12,885 | |||||
Operating expenses |
||||||||||||
Cost of revenue |
81,281 | (76,692 | ) | 4,589 | ||||||||
Sales and marketing |
13,466 | (8,155 | ) | 5,311 | ||||||||
General and administrative |
29,228 | (9,091 | ) | 20,137 | ||||||||
Research and development |
9,157 | (6,246 | ) | 2,911 | ||||||||
Amortization of intangible assets |
1,412 | (39 | ) | 1,373 | ||||||||
Impairment related and other |
753 | (644 | ) | 109 | ||||||||
|
|
|
|
|
|
|||||||
Total operating expenses |
135,297 | (100,867 | ) | 34,430 | ||||||||
|
|
|
|
|
|
|||||||
Operating income (loss) |
(1,860 | ) | (19,685 | ) | (21,545 | ) | ||||||
Other income (loss), net |
42,624 | 579 | 43,203 | |||||||||
Interest income |
393 | (32 | ) | 361 | ||||||||
Interest expense |
(577 | ) | 546 | (31 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) before income taxes, equity loss and noncontrolling interest |
40,580 | (18,592 | ) | 21,988 | ||||||||
Income tax (expense) benefit |
4,287 | (4,062 | ) | 225 | ||||||||
Equity loss |
(11,964 | ) | | (11,964 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations |
32,903 | (22,654 | ) | 10,249 | ||||||||
Less: Income (loss) from continuing operations attributable to the noncontrolling interest |
2,890 | (3,094 | ) | (204 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations attributable to ICG Group, Inc. |
$ | 30,013 | $ | (19,560 | ) | $ | 10,453 | |||||
|
|
|
|
|
|
|||||||
Basic income (loss) from continuing operations per share attributable to ICG Group, Inc.: |
$ | 0.82 | $ | (0.53 | ) | $ | 0.29 | |||||
|
|
|
|
|
|
|||||||
Shares used in computation of basic income (loss) per share |
36,656 | 36,656 | 36,656 | |||||||||
|
|
|
|
|
|
|||||||
Diluted income (loss) from continuing operations per share attributable to ICG Group, Inc.: |
$ | 0.80 | $ | (0.52 | ) | $ | 0.28 | |||||
|
|
|
|
|
|
|||||||
Shares used in computation of diluted income (loss) per share |
37,460 | 37,460 | 37,460 | |||||||||
|
|
|
|
|
|
See accompanying notes to unaudited pro forma condensed consolidated financial statements.
ICG GROUP, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
For twelve months ended December 31, 2010
(In Thousands, Except Per Share Data)
(Unaudited)
Historical ICG Group, Inc.(5) |
Sale of Procurian (7) |
Pro Forma ICG Group, Inc. |
||||||||||
Revenue |
$ | 109,213 | $ | (101,094 | ) | $ | 8,119 | |||||
Operating expenses |
||||||||||||
Cost of revenue |
67,785 | (64,870 | ) | 2,915 | ||||||||
Sales and marketing |
10,367 | (6,549 | ) | 3,818 | ||||||||
General and administrative |
28,345 | (8,655 | ) | 19,690 | ||||||||
Research and development |
7,870 | (5,697 | ) | 2,173 | ||||||||
Amortization of intangible assets |
1,357 | | 1,357 | |||||||||
Impairment related and other |
1,182 | (386 | ) | 796 | ||||||||
|
|
|
|
|
|
|||||||
Total operating expenses |
116,906 | (86,157 | ) | 30,749 | ||||||||
|
|
|
|
|
|
|||||||
Operating income (loss) |
(7,693 | ) | (14,937 | ) | (22,630 | ) | ||||||
Other income (loss), net |
74,147 | 354 | 74,501 | |||||||||
Interest income |
330 | (37 | ) | 293 | ||||||||
Interest expense |
(366 | ) | 276 | (90 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) before income taxes, equity loss and noncontrolling interest |
66,418 | (14,344 | ) | 52,074 | ||||||||
Income tax (expense) benefit |
(362 | ) | 1,473 | 1,111 | ||||||||
Equity loss |
(16,022 | ) | | (16,022 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations |
50,034 | (12,871 | ) | 37,163 | ||||||||
Less: Income (loss) from continuing operations attributable to the noncontrolling interest |
1,780 | (1,914 | ) | (134 | ) | |||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations attributable to ICG Group, Inc. |
$ | 48,254 | $ | (10,957 | ) | $ | 37,297 | |||||
|
|
|
|
|
|
|||||||
Basic income (loss) from continuing operations per share attributable to ICG Group, Inc.: |
$ | 1.33 | $ | (0.31 | ) | $ | 1.02 | |||||
|
|
|
|
|
|
|||||||
Shares used in computation of basic income (loss) per share |
36,427 | 36,427 | 36,427 | |||||||||
|
|
|
|
|
|
|||||||
Diluted income (loss) from continuing operations per share attributable to ICG Group, Inc.: |
$ | 1.30 | $ | (0.29 | ) | $ | 1.01 | |||||
|
|
|
|
|
|
|||||||
Shares used in computation of diluted income (loss) per share |
37,064 | 37,064 | 37,064 | |||||||||
|
|
|
|
|
|
See accompanying notes to unaudited pro forma condensed consolidated financial statements.
ICG Group, Inc.
Notes to the Pro Forma Condensed Consolidated Financial Statements
(Unaudited)
(1) | Amount represents sale proceeds received by ICG at closing, plus payment in connection with terminated tax sharing agreement between ICG and Procurian, less ICG transaction bonus costs (such amount, Pro Forma Cash). |
(2) | Represents adjustments to eliminate the assets and liabilities of Procurian, as well as ICGs share of Procurians transaction expenses of approximately $6.3 million. |
(3) | To record the gain on the sale of the stock of Procurian. |
The reconciliation of estimated net gain is as follows:
Pro Forma Cash plus Accrued transaction expenses |
$ | 318,644,000 | ||
Net assets sold |
(86,842,000 | ) | ||
Accrued transaction expenses |
(9,933,000 | ) | ||
Estimated net gain |
$ | 221,869,000 |
(4) | Represents the Condensed Consolidated Balance Sheet included in the Companys Quarterly Report on Form 10-Q for the period ended September 30, 2013. |
(5) | Represents the Condensed Consolidated Statements of Operations included in the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2012. |
(6) | Represents the Condensed Consolidated Statements of Operations included in the Companys Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2013. |
(7) | Represents adjustments to eliminate the results of operations of Procurians business, items that ICG believes are directly attributable to the sale, and ICGs consolidated tax positions. Those adjustments are factually supportable and will not continue after the sale of Procurian. Transaction costs are not included in the Pro Forma Condensed Consolidated Statements of Operations. The effect is to eliminate income from continuing operations of $13.5 million, $19.6 million, and $11.0 million from ICGs consolidated statements of operations for the years ended December 31, 2012, 2011 and 2010, respectively. |
(8) | Represents adjustments to eliminate ICGs consolidated tax positions; those adjustments are factually supportable and will not continue after the sale. The effect is to eliminate income from continuing operations of $1.8 million and $3.0 million from ICGs consolidated statements of operations for the nine-month periods ended September 30, 2013 and 2012, respectively. |